Por sua vez, o etoricoxibe representa um inibidor seletivo para esta enzima, apresentando seletividade superior a vezes para a COX-2 em detrimento da COX-1 21 C. Apresenta uma seletividade in vitro Conflitos de interesse. The efficacy of etoricoxib vc mefenamic acid in the treatment of primary dysmenorrhoea: A randomised comparative trial.
|Published (Last):||9 November 2016|
|PDF File Size:||13.53 Mb|
|ePub File Size:||1.66 Mb|
|Price:||Free* [*Free Regsitration Required]|
Por sua vez, o etoricoxibe representa um inibidor seletivo para esta enzima, apresentando seletividade superior a vezes para a COX-2 em detrimento da COX-1 21 C. Apresenta uma seletividade in vitro Conflitos de interesse.
The efficacy of etoricoxib vc mefenamic acid in the treatment of primary dysmenorrhoea: A randomised comparative trial. J Obstet Gynaecol. Valdecoxib, a cyclooxygenasespecific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy.
Adv Prostaglandin Thromboxane Res. Dawood MY. Clin Obstet Gynecol. Efficacy of minor analgesics in primary dysmenorrhoea: A systematic review. Br J Obstet Gynaecol. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase Nat Rev Cancer. Baron JA. Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res. Recommendations for the medical management of osteoarthritis of the hip and knee: update. Arthritis Rheum. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis.
Kidney Int. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med. Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial The MEDAL study.
Rheumatology Oxford. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term MEDAL programme: a randomised comparison.
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term MEDAL study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. Am Heart J. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Arch Intern Med. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. Etoricoxib MK : preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase J Pharmacol Exp Ther. Gynecol Obstet Invest. J Med Chem. Valdecoxib for treatment of primary dysmenorrhea.
A randomized, double-blind comparison with placebo and naproxen. J Gen Intern Med. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Dysmenorrhea treatment with a single daily dose of rofecoxib. Int J Gynaecol Obstet. Evans AM. J Clin Pharmacol. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol. ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial. Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea. Int J Clin Pract.
Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal anti-inflammatory drugs. Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhea. The analgesic and anti-inflammatory activity and pharmacologic properties of bromfenac.
A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea. J Womens Health.
Oxicams-anovel family of non-steroidal anti-inflammatory drugs. Eur J Rheumatol Inflamm. A double-blind, placebo-controlled study comparing three single-dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Services on Demand Journal. How to cite this article.
Louis, v. Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenac. European journal of obstetrics, gynecology, and reproductive biology, Amsterdam, v. Acesso em: 08 jan. Prevalence of primary dysmenorrhea in young adult female university students. Archives of gynecology and obstetrics, Berlin, v. Femina, Rio de Janeiro, v.
Membranous dysmenorrhea - a forgotten disease. METHODS: all the patients selected were under diagnostic suspicion, after being clinically attended in a private medical office due to the report of painful dysmenorrhea associated with spontaneous elimination of elastic material with uterine shape. Only relevant facts about the pain condition have been described, together with the present and previous medical history and life habits. The material eliminated was forwarded to the pathology laboratory, where the macro and microscopic analyses were done.